Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SUWN Looking for the bounce back to the .28 area.
Hope yall got it for the double. looking to SUWN to run next.From .21 entry.
122,175 shares ALL BUYS at the end.This thing should smoke tomorrow. SUWN.OB
massive buy orders in Suwn towards the EOD. Might take off tomorrow.
SUWN big seller appears gone. Should bounce up nicely. .21x.22
SUWN big seller appears gone....up we go!!
SUWN once seller leaves it should race quickly back to the .28 area. The only time you can buy this low is after a big owner sells.The window of opportunity might not last long. Irregardless it will go back up over time esp. as profits will likely multiply on stevia deal.Expected benefits of partnership for WILD Flavors’ Customers:
Market potential and growth – quick commercialization of product and concepts
Customized product application – all-natural stevia extracts combined with WILD Flavors’ taste modification technologies, customized for proprietary, unique sweetening systems
Potential for“All-Natural” and “Low Glycemic” claims
Solutions for low-calorie concepts or sugar reduction - zero-calories for stevia, and minimal calories for the sweetening blends
Supply of highest quality of stevia extracts through controlled processes that customers can rely on
Expected benefits of partnership for Sunwin International:
$3 million for substantial equity position - for growth capital to expand production of its Rebaudioside A80 and A95 extracts to meet growing worldwide demand and the anticipated increased sales from the partnership
Services valued in excess of $1 Million – office, sales, certifications, quality management, production improvement, and other services provided by WILD Flavors.
Increased market potential - for the food and beverage industry through creative sweetening blends as well as bulk stevia extract and table-top sweetener sales, all with great taste as a foundation
Total quality management – WILD Flavors will utilize its recognized quality and safety protocols to enhance Sunwin International’s procedures and processes in accordance to the standards required when developing supplier relationships with consumer packaged goods companies.
Stevia Innovation – Sunwin International will be leveraging WILD Flavors’ innovative flavor technologies and customer relationships to expand sales to companies who are interested in stevia.
Worldwide Reach – WILD Flavors’ worldwide presence through its relationships with allied organizations gives Sunwin International the ability to access global markets and customers.http://www.wildflavors.com/?fuseaction=n...
yep . I had originally posted my thoughts then decided to keep it a secret. If they decide to keeep dumping i would think .17 might be your best price to get in. I couldnt get filled at .18 today so i went on and took out the ask. oh well.Just for the hell of it u could put in a offer at .16 which might offer some cheap profits on a big seller.
Buying on this dump.
test
And also can't the holders of these newly minted shares acutualy short the stock based on their new equity position?Another reason for ACTC not to file.IMHO this baby runs on momo and speculation.If any govt. help is delayed too long the momo will fall off followed by a bad selloff. To keep your assets safe it is prudent to sell some of your shares on the way up.This puts some of your invested money back in your pocket and you can withstand any future downward spirals.You can tell yourself .50 or so upside but noone really knows.And like all penny runs you dont know when the music will stop.This board is full of cheerleaders so be careful. Its your dime, noone elses. Protect yourself and be smart in taking profits.Good habits like this will protect yourself down your investing future. GLA
They sold waaaay to cheaply.Should be a good synergy but did they need the mula that bad to come to such terms?
Weeeeeeeeeeeee.What a chart!
CASTLE ROCK, CO--(MARKET WIRE)--Feb 11, 2009 -- AspenBio Pharma, Inc. (NasdaqCM:APPY - News), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has appointed Robert F. Caspari, M.D. to the new positions of chief operating officer and chief medical officer. His initial primary responsibilities will include managing the development, FDA clinical trial and submission activities for AppyScore(TM), the company's breakthrough diagnostic test for human appendicitis.http://biz.yahoo.com/iw/090211/0473436.html
APPY From Yahoo. Daryl J. Faulkner...Will He Be the Hero 9-Feb-09 11:04 pm I think so. He got his 500,000 shares in the $1.50 range. Now he can make some real money if he gets APPY going again.
What if this small sample on the test was reported in a bad light.
I am sure they will talk next week and explaing that THE TEST IS 98% ACCURATE WHEN THE WHITE BLOOD CELL COUNT IS IN LINE.
Go ahead and submit the 510k. Bingo, you get approval and a $20+ stock. All the movement should start happening right after 2/18 when Mr. Faulkner fires up the investors.
Unless of course the holdout Republicans want to make govt funding of stem cell research and issue.Democrats are willing to bargain to get the stimulus bill passed. Keeping my fingers crossed.
ACLS Dirt cheap semi stock here, notice Intel moving up big this week, ACLS sports over $3 per share net tangible book value and stockholder equity, will not be surprised if another buyout proposal comes this month.
http://www.solid-state.com/display_article/319788/5/ONART/none/BIZNW/Sumitomo,-Axcelis-argue-over-unsolicited-takeover-bid?dcmp=rss
ACLS moving up fast.
Futures Fall as Bank Bailout is Delayed
US stocks looked set to hand back some of last week’s gains at the open Monday as the much-anticipated bank rescue plan was delayed for another day.
It is hoped the delay will give lawmakers time to settle their differences over a huge economic stimulus package, on which a vote is due Tuesday. Top aides to President Barack Obama urged Democratic and Republican lawmakers to set aside party politics in the hope of ensuring final approval for the plan. http://www.cnbc.com//id/29095597?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahoo
ACLS getting bid up in premarket. .28-.31
APPY will make you HAPPY......http://www.reuters.com/article/marketsNews/idINBNG43095520090209?rpc=44
You are correct. My bad.
If the bill doesnt get passed by EOD Tuesday we will see some major price gyrations.Still is possible to get in on the cheap.
profit taking. buy on the dips. never chase
if there is any delay in the signing you can buy on the dip.Buy low. Never chase.
Sorry Miss. you can keep your cheerleading to yourself.a little truth leads to much better understanding of what is going on.I want ACTC to do well also.But i will not just adhere to pom-pom tactics.
Youre crazy as chit. Cha and ACTC are joined at the hip.
Verdict on Stem Cell Research Delayed
By Kim Tong-hyung, Staff Reporter Korea Times, 02-05-2009
The government is reluctant to make a quick decision on whether to allow local scientists to resume research on cloned human stem cells, with disturbing memories of Hwang Woo-suk still fresh in the air.
After a lengthy meeting Thursday, the National Bioethics Committee decided to delay its decision over whether to allow the Seoul-based Cha Medical Center to conduct research on embryonic stem cells created from cloned human embryos.
Research on cloned human stem cells has been halted in Korea since 2006, when the bioethics committee banned Hwang from continuing his efforts after his landmark studies were exposed as fraudulent.
The Cha Medical Center had applied for approval on therapeutic cloning, claiming that the methods are crucial in developing more effective treatments for Parkinson's diseases, spinal injuries, diabetes, cardiovascular disorders and other difficult medical conditions.
However, in delaying its verdict, the committee demanded the hospital submit a more detailed plan for research. The Cha Medial Center plans to reapply in two or three months, according to officials at the hospital.
The embryonic stem cell research described by the Cha Medical Center involves the process of cloning, whereby the nucleus of a somatic cell of a patient is transferred to an egg with no nucleus. The created embryo is used to harvest stem cells and grow them into the type of tissue needed for treatment.
Scientists claim that the method would open new opportunities in developing patient-specific treatment and eliminate tissue rejection during transplants, and allow them to secure a larger amount of stem cells for research.
However, the destruction of human embryos in the process, as well as the ethics debate surrounding cloning, makes the technology controversial.
Hwang, formerly a researcher at Seoul National University (SNU), reached rock-star status, rare for a scientist, in 2005, by claiming to have created cloned embryos from patient-specific embryonic stem cells.
But he was fired from the school a year later after the studies were deemed fraudulent.
thkim@koreatimes.co.kr
adding
usually it means we should get a bounce up from here.http://www.swing-trade-stocks.com/fibonacci-retracements.html
under the Bush admin. with anti-stem cell agenda you had to take what you could get.
there are actually 3 news events on the horizon. Stem cell ban revoked, Obama stimulus package and funds rolling in to begin testing. "The Company is close to securing the necessary funding which would allow it to make the requisite filings during the summer of this year. ".......http://biz.yahoo.com/bw/090123/20090123005486.html?.v=1
Once stimulus bill passes we should see a decent spike of .10 or more. patience
Reloading.
cbai partners with BlueCross
http://www.msbcbs.com/corcell/members.html
ATHX the ONLY stem cell stock trading BELOW cash......$1.70 cash per share
What's amazing is that GERN has zero debt, and over $150M in the bank. That's more than more banks have these days